Analysts expect Addus HomeCare (NASDAQ:ADUS) to report $127.81 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Addus HomeCare’s earnings, with the highest sales estimate coming in at $131.52 million and the lowest estimate coming in at $124.10 million. Addus HomeCare reported sales of $103.56 million during the same quarter last year, which indicates a positive year-over-year growth rate of 23.4%. The business is expected to announce its next quarterly earnings results on Monday, August 6th.
According to Zacks, analysts expect that Addus HomeCare will report full year sales of $517.33 million for the current year, with estimates ranging from $515.90 million to $518.76 million. For the next financial year, analysts expect that the business will report sales of $572.20 million per share, with estimates ranging from $567.39 million to $577.00 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Addus HomeCare.
Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, March 5th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.39 by $0.03. The firm had revenue of $111.96 million for the quarter, compared to the consensus estimate of $110.82 million. Addus HomeCare had a net margin of 3.28% and a return on equity of 10.04%.
Several research firms have commented on ADUS. BidaskClub downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 12th. Zacks Investment Research downgraded shares of Addus HomeCare from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 13th. ValuEngine raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Stephens set a $56.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Monday, April 2nd. Finally, Robert W. Baird set a $43.00 price target on shares of Addus HomeCare and gave the stock a “hold” rating in a research note on Wednesday, March 14th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Addus HomeCare currently has an average rating of “Buy” and a consensus price target of $51.00.
In related news, insider James Zoccoli sold 725 shares of Addus HomeCare stock in a transaction on Monday, February 26th. The shares were sold at an average price of $35.90, for a total value of $26,027.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Brian Poff sold 613 shares of Addus HomeCare stock in a transaction on Thursday, May 10th. The stock was sold at an average price of $52.95, for a total transaction of $32,458.35. Following the completion of the transaction, the chief financial officer now directly owns 22,770 shares in the company, valued at $1,205,671.50. The disclosure for this sale can be found here. Insiders have sold 6,151 shares of company stock worth $230,678 over the last three months. Insiders own 35.80% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of ADUS. MetLife Investment Advisors LLC purchased a new position in shares of Addus HomeCare in the fourth quarter worth $146,000. Dorsey & Whitney Trust CO LLC purchased a new position in shares of Addus HomeCare in the first quarter worth $211,000. Connors Investor Services Inc. purchased a new position in shares of Addus HomeCare in the first quarter worth $234,000. Goldman Sachs Group Inc. purchased a new position in shares of Addus HomeCare in the fourth quarter worth $258,000. Finally, Monarch Partners Asset Management LLC purchased a new position in shares of Addus HomeCare in the first quarter worth $423,000. 59.84% of the stock is currently owned by institutional investors.
Shares of Addus HomeCare traded down $0.10, hitting $52.90, during trading hours on Monday, MarketBeat reports. 124,294 shares of the company’s stock were exchanged, compared to its average volume of 47,411. The company has a market capitalization of $617.94 million, a PE ratio of 36.48, a price-to-earnings-growth ratio of 1.77 and a beta of -0.40. Addus HomeCare has a 12-month low of $30.95 and a 12-month high of $55.75. The company has a debt-to-equity ratio of 0.22, a quick ratio of 3.01 and a current ratio of 3.01.
Addus HomeCare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.